nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP1A2—type 2 diabetes mellitus	0.242	0.602	CbGaD
Palonosetron—CYP3A4—type 2 diabetes mellitus	0.16	0.398	CbGaD
Palonosetron—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0329	0.0843	CbGbCtD
Palonosetron—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0294	0.0753	CbGbCtD
Palonosetron—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.029	0.0743	CbGbCtD
Palonosetron—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0271	0.0695	CbGbCtD
Palonosetron—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0259	0.0664	CbGbCtD
Palonosetron—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0258	0.0662	CbGbCtD
Palonosetron—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0245	0.0628	CbGbCtD
Palonosetron—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0236	0.0605	CbGbCtD
Palonosetron—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0223	0.057	CbGbCtD
Palonosetron—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0214	0.0547	CbGbCtD
Palonosetron—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0207	0.0529	CbGbCtD
Palonosetron—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0187	0.0479	CbGbCtD
Palonosetron—CYP1A2—Losartan—type 2 diabetes mellitus	0.0167	0.0428	CbGbCtD
Palonosetron—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0142	0.0363	CbGbCtD
Palonosetron—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0136	0.0348	CbGbCtD
Palonosetron—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0136	0.0348	CbGbCtD
Palonosetron—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0128	0.0329	CbGbCtD
Palonosetron—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00957	0.0245	CbGbCtD
Palonosetron—CYP3A4—Losartan—type 2 diabetes mellitus	0.00875	0.0224	CbGbCtD
Palonosetron—Praziquantel—CYP1A2—type 2 diabetes mellitus	0.00175	0.602	CrCbGaD
Palonosetron—Praziquantel—CYP3A4—type 2 diabetes mellitus	0.00116	0.398	CrCbGaD
Palonosetron—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000138	0.000828	CcSEcCtD
Palonosetron—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000138	0.000828	CcSEcCtD
Palonosetron—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000138	0.000827	CcSEcCtD
Palonosetron—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000138	0.000827	CcSEcCtD
Palonosetron—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000138	0.000826	CcSEcCtD
Palonosetron—Hypertension—Metformin—type 2 diabetes mellitus	0.000137	0.000822	CcSEcCtD
Palonosetron—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000137	0.000819	CcSEcCtD
Palonosetron—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000137	0.000818	CcSEcCtD
Palonosetron—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000137	0.000818	CcSEcCtD
Palonosetron—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000137	0.000817	CcSEcCtD
Palonosetron—Anorexia—Valsartan—type 2 diabetes mellitus	0.000136	0.000813	CcSEcCtD
Palonosetron—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000136	0.000812	CcSEcCtD
Palonosetron—Myalgia—Metformin—type 2 diabetes mellitus	0.000135	0.000811	CcSEcCtD
Palonosetron—Headache—Pioglitazone—type 2 diabetes mellitus	0.000135	0.000807	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000134	0.000805	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000134	0.000802	CcSEcCtD
Palonosetron—Discomfort—Metformin—type 2 diabetes mellitus	0.000134	0.000801	CcSEcCtD
Palonosetron—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000134	0.000801	CcSEcCtD
Palonosetron—Nausea—Glipizide—type 2 diabetes mellitus	0.000133	0.000798	CcSEcCtD
Palonosetron—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000133	0.000797	CcSEcCtD
Palonosetron—Hypotension—Valsartan—type 2 diabetes mellitus	0.000133	0.000797	CcSEcCtD
Palonosetron—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000133	0.000795	CcSEcCtD
Palonosetron—Pain—Gliclazide—type 2 diabetes mellitus	0.000133	0.000794	CcSEcCtD
Palonosetron—Constipation—Gliclazide—type 2 diabetes mellitus	0.000133	0.000794	CcSEcCtD
Palonosetron—Rash—Glimepiride—type 2 diabetes mellitus	0.000132	0.000791	CcSEcCtD
Palonosetron—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000132	0.00079	CcSEcCtD
Palonosetron—Rash—Sitagliptin—type 2 diabetes mellitus	0.000132	0.000788	CcSEcCtD
Palonosetron—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000132	0.000787	CcSEcCtD
Palonosetron—Headache—Glimepiride—type 2 diabetes mellitus	0.000131	0.000786	CcSEcCtD
Palonosetron—Headache—Sitagliptin—type 2 diabetes mellitus	0.000131	0.000783	CcSEcCtD
Palonosetron—Anaemia—Losartan—type 2 diabetes mellitus	0.000131	0.000781	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00013	0.000777	CcSEcCtD
Palonosetron—Tinnitus—Ramipril—type 2 diabetes mellitus	0.00013	0.000777	CcSEcCtD
Palonosetron—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00013	0.000776	CcSEcCtD
Palonosetron—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000129	0.000774	CcSEcCtD
Palonosetron—Infection—Metformin—type 2 diabetes mellitus	0.000129	0.000772	CcSEcCtD
Palonosetron—Insomnia—Valsartan—type 2 diabetes mellitus	0.000129	0.000772	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000128	0.000768	CcSEcCtD
Palonosetron—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000128	0.000766	CcSEcCtD
Palonosetron—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000128	0.000765	CcSEcCtD
Palonosetron—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000128	0.000765	CcSEcCtD
Palonosetron—Shock—Metformin—type 2 diabetes mellitus	0.000128	0.000764	CcSEcCtD
Palonosetron—Insomnia—Orlistat—type 2 diabetes mellitus	0.000127	0.000763	CcSEcCtD
Palonosetron—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000127	0.000762	CcSEcCtD
Palonosetron—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000127	0.000762	CcSEcCtD
Palonosetron—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000127	0.000762	CcSEcCtD
Palonosetron—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000127	0.000761	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000127	0.00076	CcSEcCtD
Palonosetron—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000127	0.000759	CcSEcCtD
Palonosetron—Somnolence—Valsartan—type 2 diabetes mellitus	0.000127	0.000759	CcSEcCtD
Palonosetron—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000126	0.000757	CcSEcCtD
Palonosetron—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000126	0.000756	CcSEcCtD
Palonosetron—Skin disorder—Metformin—type 2 diabetes mellitus	0.000126	0.000755	CcSEcCtD
Palonosetron—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000126	0.000752	CcSEcCtD
Palonosetron—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000125	0.000751	CcSEcCtD
Palonosetron—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000125	0.000751	CcSEcCtD
Palonosetron—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000125	0.000748	CcSEcCtD
Palonosetron—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000125	0.000748	CcSEcCtD
Palonosetron—Nausea—Glimepiride—type 2 diabetes mellitus	0.000124	0.000745	CcSEcCtD
Palonosetron—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000124	0.000744	CcSEcCtD
Palonosetron—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000124	0.000743	CcSEcCtD
Palonosetron—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000124	0.000742	CcSEcCtD
Palonosetron—Asthenia—Glyburide—type 2 diabetes mellitus	0.000124	0.000742	CcSEcCtD
Palonosetron—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000124	0.000742	CcSEcCtD
Palonosetron—Anorexia—Metformin—type 2 diabetes mellitus	0.000124	0.000741	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000123	0.000737	CcSEcCtD
Palonosetron—Alopecia—Ramipril—type 2 diabetes mellitus	0.000123	0.000736	CcSEcCtD
Palonosetron—Fatigue—Valsartan—type 2 diabetes mellitus	0.000123	0.000736	CcSEcCtD
Palonosetron—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000123	0.000734	CcSEcCtD
Palonosetron—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000123	0.000734	CcSEcCtD
Palonosetron—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000123	0.000733	CcSEcCtD
Palonosetron—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000122	0.000733	CcSEcCtD
Palonosetron—Pruritus—Glyburide—type 2 diabetes mellitus	0.000122	0.000732	CcSEcCtD
Palonosetron—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000122	0.00073	CcSEcCtD
Palonosetron—Constipation—Valsartan—type 2 diabetes mellitus	0.000122	0.00073	CcSEcCtD
Palonosetron—Infection—Irbesartan—type 2 diabetes mellitus	0.000122	0.000728	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000122	0.000728	CcSEcCtD
Palonosetron—Fatigue—Orlistat—type 2 diabetes mellitus	0.000121	0.000727	CcSEcCtD
Palonosetron—Hypotension—Metformin—type 2 diabetes mellitus	0.000121	0.000726	CcSEcCtD
Palonosetron—Erythema—Ramipril—type 2 diabetes mellitus	0.000121	0.000725	CcSEcCtD
Palonosetron—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000121	0.000725	CcSEcCtD
Palonosetron—Shock—Irbesartan—type 2 diabetes mellitus	0.000121	0.000721	CcSEcCtD
Palonosetron—Pain—Orlistat—type 2 diabetes mellitus	0.00012	0.000721	CcSEcCtD
Palonosetron—Myalgia—Losartan—type 2 diabetes mellitus	0.00012	0.00072	CcSEcCtD
Palonosetron—Arthralgia—Losartan—type 2 diabetes mellitus	0.00012	0.00072	CcSEcCtD
Palonosetron—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00012	0.000719	CcSEcCtD
Palonosetron—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00012	0.000719	CcSEcCtD
Palonosetron—Anxiety—Losartan—type 2 diabetes mellitus	0.00012	0.000717	CcSEcCtD
Palonosetron—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00012	0.000716	CcSEcCtD
Palonosetron—Rash—Bromocriptine—type 2 diabetes mellitus	0.000119	0.000713	CcSEcCtD
Palonosetron—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000119	0.000713	CcSEcCtD
Palonosetron—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000119	0.000712	CcSEcCtD
Palonosetron—Discomfort—Losartan—type 2 diabetes mellitus	0.000119	0.000711	CcSEcCtD
Palonosetron—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000119	0.00071	CcSEcCtD
Palonosetron—Headache—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000709	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000118	0.000708	CcSEcCtD
Palonosetron—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000118	0.000708	CcSEcCtD
Palonosetron—Dry mouth—Losartan—type 2 diabetes mellitus	0.000118	0.000704	CcSEcCtD
Palonosetron—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000117	0.000699	CcSEcCtD
Palonosetron—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000117	0.000698	CcSEcCtD
Palonosetron—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000117	0.000698	CcSEcCtD
Palonosetron—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000116	0.000693	CcSEcCtD
Palonosetron—Somnolence—Metformin—type 2 diabetes mellitus	0.000115	0.000691	CcSEcCtD
Palonosetron—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000115	0.00069	CcSEcCtD
Palonosetron—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000115	0.000689	CcSEcCtD
Palonosetron—Infection—Losartan—type 2 diabetes mellitus	0.000115	0.000686	CcSEcCtD
Palonosetron—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000114	0.000685	CcSEcCtD
Palonosetron—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000114	0.000684	CcSEcCtD
Palonosetron—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000114	0.000684	CcSEcCtD
Palonosetron—Shock—Losartan—type 2 diabetes mellitus	0.000113	0.000679	CcSEcCtD
Palonosetron—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000113	0.000677	CcSEcCtD
Palonosetron—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000113	0.000675	CcSEcCtD
Palonosetron—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000113	0.000674	CcSEcCtD
Palonosetron—Tachycardia—Losartan—type 2 diabetes mellitus	0.000113	0.000673	CcSEcCtD
Palonosetron—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000672	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000112	0.000671	CcSEcCtD
Palonosetron—Fatigue—Metformin—type 2 diabetes mellitus	0.000112	0.00067	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000112	0.000668	CcSEcCtD
Palonosetron—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000111	0.000666	CcSEcCtD
Palonosetron—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000111	0.000666	CcSEcCtD
Palonosetron—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000111	0.000666	CcSEcCtD
Palonosetron—Constipation—Metformin—type 2 diabetes mellitus	0.000111	0.000664	CcSEcCtD
Palonosetron—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00011	0.000658	CcSEcCtD
Palonosetron—Anorexia—Losartan—type 2 diabetes mellitus	0.00011	0.000658	CcSEcCtD
Palonosetron—Vomiting—Glyburide—type 2 diabetes mellitus	0.00011	0.000658	CcSEcCtD
Palonosetron—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00011	0.000657	CcSEcCtD
Palonosetron—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000109	0.000654	CcSEcCtD
Palonosetron—Rash—Glyburide—type 2 diabetes mellitus	0.000109	0.000652	CcSEcCtD
Palonosetron—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000109	0.000652	CcSEcCtD
Palonosetron—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000109	0.000651	CcSEcCtD
Palonosetron—Headache—Glyburide—type 2 diabetes mellitus	0.000108	0.000648	CcSEcCtD
Palonosetron—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000108	0.000645	CcSEcCtD
Palonosetron—Hypotension—Losartan—type 2 diabetes mellitus	0.000108	0.000645	CcSEcCtD
Palonosetron—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000107	0.000637	CcSEcCtD
Palonosetron—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000106	0.000635	CcSEcCtD
Palonosetron—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000106	0.000635	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000106	0.000633	CcSEcCtD
Palonosetron—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000106	0.000632	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000105	0.000629	CcSEcCtD
Palonosetron—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000105	0.000629	CcSEcCtD
Palonosetron—Convulsion—Ramipril—type 2 diabetes mellitus	0.000105	0.000628	CcSEcCtD
Palonosetron—Constipation—Irbesartan—type 2 diabetes mellitus	0.000105	0.000627	CcSEcCtD
Palonosetron—Pain—Irbesartan—type 2 diabetes mellitus	0.000105	0.000627	CcSEcCtD
Palonosetron—Insomnia—Losartan—type 2 diabetes mellitus	0.000104	0.000624	CcSEcCtD
Palonosetron—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000104	0.000621	CcSEcCtD
Palonosetron—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000104	0.00062	CcSEcCtD
Palonosetron—Myalgia—Ramipril—type 2 diabetes mellitus	0.000103	0.000617	CcSEcCtD
Palonosetron—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000103	0.000617	CcSEcCtD
Palonosetron—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000103	0.000615	CcSEcCtD
Palonosetron—Anxiety—Ramipril—type 2 diabetes mellitus	0.000103	0.000615	CcSEcCtD
Palonosetron—Nausea—Glyburide—type 2 diabetes mellitus	0.000103	0.000614	CcSEcCtD
Palonosetron—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000103	0.000614	CcSEcCtD
Palonosetron—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000103	0.000614	CcSEcCtD
Palonosetron—Somnolence—Losartan—type 2 diabetes mellitus	0.000103	0.000613	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000102	0.000613	CcSEcCtD
Palonosetron—Asthenia—Valsartan—type 2 diabetes mellitus	0.000102	0.000612	CcSEcCtD
Palonosetron—Discomfort—Ramipril—type 2 diabetes mellitus	0.000102	0.00061	CcSEcCtD
Palonosetron—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000101	0.000607	CcSEcCtD
Palonosetron—Asthenia—Orlistat—type 2 diabetes mellitus	0.000101	0.000605	CcSEcCtD
Palonosetron—Pruritus—Valsartan—type 2 diabetes mellitus	0.000101	0.000604	CcSEcCtD
Palonosetron—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000101	0.000604	CcSEcCtD
Palonosetron—Decreased appetite—Losartan—type 2 diabetes mellitus	0.0001	0.0006	CcSEcCtD
Palonosetron—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.0001	0.0006	CcSEcCtD
Palonosetron—Pruritus—Orlistat—type 2 diabetes mellitus	9.97e-05	0.000596	CcSEcCtD
Palonosetron—Fatigue—Losartan—type 2 diabetes mellitus	9.94e-05	0.000595	CcSEcCtD
Palonosetron—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.89e-05	0.000592	CcSEcCtD
Palonosetron—Vomiting—Gliclazide—type 2 diabetes mellitus	9.87e-05	0.00059	CcSEcCtD
Palonosetron—Pain—Losartan—type 2 diabetes mellitus	9.86e-05	0.00059	CcSEcCtD
Palonosetron—Constipation—Losartan—type 2 diabetes mellitus	9.86e-05	0.00059	CcSEcCtD
Palonosetron—Rash—Gliclazide—type 2 diabetes mellitus	9.78e-05	0.000586	CcSEcCtD
Palonosetron—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.77e-05	0.000585	CcSEcCtD
Palonosetron—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.75e-05	0.000584	CcSEcCtD
Palonosetron—Shock—Ramipril—type 2 diabetes mellitus	9.73e-05	0.000582	CcSEcCtD
Palonosetron—Headache—Gliclazide—type 2 diabetes mellitus	9.72e-05	0.000582	CcSEcCtD
Palonosetron—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.7e-05	0.00058	CcSEcCtD
Palonosetron—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.69e-05	0.00058	CcSEcCtD
Palonosetron—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.69e-05	0.00058	CcSEcCtD
Palonosetron—Tachycardia—Ramipril—type 2 diabetes mellitus	9.65e-05	0.000577	CcSEcCtD
Palonosetron—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.64e-05	0.000577	CcSEcCtD
Palonosetron—Skin disorder—Ramipril—type 2 diabetes mellitus	9.6e-05	0.000575	CcSEcCtD
Palonosetron—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.43e-05	0.000564	CcSEcCtD
Palonosetron—Dizziness—Valsartan—type 2 diabetes mellitus	9.43e-05	0.000564	CcSEcCtD
Palonosetron—Anorexia—Ramipril—type 2 diabetes mellitus	9.42e-05	0.000564	CcSEcCtD
Palonosetron—Dizziness—Orlistat—type 2 diabetes mellitus	9.32e-05	0.000558	CcSEcCtD
Palonosetron—Asthenia—Metformin—type 2 diabetes mellitus	9.31e-05	0.000557	CcSEcCtD
Palonosetron—Hypotension—Ramipril—type 2 diabetes mellitus	9.24e-05	0.000553	CcSEcCtD
Palonosetron—Nausea—Gliclazide—type 2 diabetes mellitus	9.22e-05	0.000552	CcSEcCtD
Palonosetron—Pruritus—Metformin—type 2 diabetes mellitus	9.19e-05	0.00055	CcSEcCtD
Palonosetron—Abdominal pain—Losartan—type 2 diabetes mellitus	9.11e-05	0.000545	CcSEcCtD
Palonosetron—Body temperature increased—Losartan—type 2 diabetes mellitus	9.11e-05	0.000545	CcSEcCtD
Palonosetron—Vomiting—Valsartan—type 2 diabetes mellitus	9.06e-05	0.000542	CcSEcCtD
Palonosetron—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.03e-05	0.00054	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000539	CcSEcCtD
Palonosetron—Rash—Valsartan—type 2 diabetes mellitus	8.99e-05	0.000538	CcSEcCtD
Palonosetron—Dermatitis—Valsartan—type 2 diabetes mellitus	8.98e-05	0.000537	CcSEcCtD
Palonosetron—Vomiting—Orlistat—type 2 diabetes mellitus	8.96e-05	0.000536	CcSEcCtD
Palonosetron—Insomnia—Ramipril—type 2 diabetes mellitus	8.94e-05	0.000535	CcSEcCtD
Palonosetron—Headache—Valsartan—type 2 diabetes mellitus	8.93e-05	0.000535	CcSEcCtD
Palonosetron—Diarrhoea—Metformin—type 2 diabetes mellitus	8.88e-05	0.000532	CcSEcCtD
Palonosetron—Rash—Orlistat—type 2 diabetes mellitus	8.88e-05	0.000532	CcSEcCtD
Palonosetron—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.88e-05	0.000531	CcSEcCtD
Palonosetron—Dermatitis—Orlistat—type 2 diabetes mellitus	8.87e-05	0.000531	CcSEcCtD
Palonosetron—Headache—Orlistat—type 2 diabetes mellitus	8.83e-05	0.000528	CcSEcCtD
Palonosetron—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.81e-05	0.000528	CcSEcCtD
Palonosetron—Asthenia—Irbesartan—type 2 diabetes mellitus	8.79e-05	0.000526	CcSEcCtD
Palonosetron—Somnolence—Ramipril—type 2 diabetes mellitus	8.79e-05	0.000526	CcSEcCtD
Palonosetron—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.7e-05	0.000521	CcSEcCtD
Palonosetron—Pruritus—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.000519	CcSEcCtD
Palonosetron—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000514	CcSEcCtD
Palonosetron—Dizziness—Metformin—type 2 diabetes mellitus	8.59e-05	0.000514	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000511	CcSEcCtD
Palonosetron—Fatigue—Ramipril—type 2 diabetes mellitus	8.52e-05	0.00051	CcSEcCtD
Palonosetron—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.49e-05	0.000508	CcSEcCtD
Palonosetron—Nausea—Valsartan—type 2 diabetes mellitus	8.47e-05	0.000507	CcSEcCtD
Palonosetron—Constipation—Ramipril—type 2 diabetes mellitus	8.45e-05	0.000506	CcSEcCtD
Palonosetron—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.38e-05	0.000502	CcSEcCtD
Palonosetron—Nausea—Orlistat—type 2 diabetes mellitus	8.37e-05	0.000501	CcSEcCtD
Palonosetron—Asthenia—Losartan—type 2 diabetes mellitus	8.27e-05	0.000495	CcSEcCtD
Palonosetron—Vomiting—Metformin—type 2 diabetes mellitus	8.25e-05	0.000494	CcSEcCtD
Palonosetron—Rash—Metformin—type 2 diabetes mellitus	8.19e-05	0.00049	CcSEcCtD
Palonosetron—Dermatitis—Metformin—type 2 diabetes mellitus	8.18e-05	0.000489	CcSEcCtD
Palonosetron—Pruritus—Losartan—type 2 diabetes mellitus	8.16e-05	0.000488	CcSEcCtD
Palonosetron—Headache—Metformin—type 2 diabetes mellitus	8.13e-05	0.000487	CcSEcCtD
Palonosetron—Dizziness—Irbesartan—type 2 diabetes mellitus	8.1e-05	0.000485	CcSEcCtD
Palonosetron—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.08e-05	0.000484	CcSEcCtD
Palonosetron—Diarrhoea—Losartan—type 2 diabetes mellitus	7.89e-05	0.000472	CcSEcCtD
Palonosetron—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.82e-05	0.000468	CcSEcCtD
Palonosetron—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.82e-05	0.000468	CcSEcCtD
Palonosetron—Vomiting—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.000466	CcSEcCtD
Palonosetron—Rash—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000462	CcSEcCtD
Palonosetron—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000462	CcSEcCtD
Palonosetron—Nausea—Metformin—type 2 diabetes mellitus	7.71e-05	0.000462	CcSEcCtD
Palonosetron—Headache—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000459	CcSEcCtD
Palonosetron—Dizziness—Losartan—type 2 diabetes mellitus	7.62e-05	0.000456	CcSEcCtD
Palonosetron—Vomiting—Losartan—type 2 diabetes mellitus	7.33e-05	0.000439	CcSEcCtD
Palonosetron—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000436	CcSEcCtD
Palonosetron—Nausea—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000436	CcSEcCtD
Palonosetron—Rash—Losartan—type 2 diabetes mellitus	7.27e-05	0.000435	CcSEcCtD
Palonosetron—Dermatitis—Losartan—type 2 diabetes mellitus	7.26e-05	0.000435	CcSEcCtD
Palonosetron—Headache—Losartan—type 2 diabetes mellitus	7.22e-05	0.000432	CcSEcCtD
Palonosetron—Asthenia—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000425	CcSEcCtD
Palonosetron—Pruritus—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000419	CcSEcCtD
Palonosetron—Nausea—Losartan—type 2 diabetes mellitus	6.85e-05	0.00041	CcSEcCtD
Palonosetron—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.76e-05	0.000405	CcSEcCtD
Palonosetron—Dizziness—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000391	CcSEcCtD
Palonosetron—Vomiting—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000376	CcSEcCtD
Palonosetron—Rash—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000373	CcSEcCtD
Palonosetron—Dermatitis—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000373	CcSEcCtD
Palonosetron—Headache—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000371	CcSEcCtD
Palonosetron—Nausea—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000351	CcSEcCtD
Palonosetron—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	1.65e-05	0.000451	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	1.65e-05	0.000451	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.65e-05	0.00045	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.64e-05	0.000449	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.64e-05	0.000449	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.61e-05	0.000439	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	1.6e-05	0.000437	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.6e-05	0.000436	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.57e-05	0.000428	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.55e-05	0.000423	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.53e-05	0.000418	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	1.51e-05	0.000412	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	1.51e-05	0.000412	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	1.47e-05	0.000402	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.45e-05	0.000395	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.45e-05	0.000395	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.44e-05	0.000394	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.42e-05	0.000386	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	1.4e-05	0.000383	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	1.4e-05	0.000383	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	1.4e-05	0.000383	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.4e-05	0.000383	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	1.4e-05	0.000382	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	1.4e-05	0.000382	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	1.4e-05	0.000382	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	1.4e-05	0.000382	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.4e-05	0.000382	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	1.35e-05	0.00037	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	1.35e-05	0.000367	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	1.35e-05	0.000367	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.34e-05	0.000366	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.34e-05	0.000366	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	1.3e-05	0.000354	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	1.3e-05	0.000354	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.28e-05	0.000349	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.28e-05	0.000349	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	1.27e-05	0.000347	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.27e-05	0.000347	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.27e-05	0.000347	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	1.25e-05	0.000342	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	1.25e-05	0.000342	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	1.25e-05	0.000342	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	1.25e-05	0.00034	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.21e-05	0.000331	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.19e-05	0.000325	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.19e-05	0.000325	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.19e-05	0.000325	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.18e-05	0.000321	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.14e-05	0.000311	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.14e-05	0.000311	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.12e-05	0.000305	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.12e-05	0.000305	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.1e-05	0.000301	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.1e-05	0.0003	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.1e-05	0.0003	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.08e-05	0.000295	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.08e-05	0.000295	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.08e-05	0.000295	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.08e-05	0.000295	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.08e-05	0.000295	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.08e-05	0.000294	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.08e-05	0.000294	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.06e-05	0.00029	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.06e-05	0.00029	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.06e-05	0.00029	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.06e-05	0.00029	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.06e-05	0.000289	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.06e-05	0.000289	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.06e-05	0.000289	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.05e-05	0.000285	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.03e-05	0.000281	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.02e-05	0.000278	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	9.96e-06	0.000272	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	9.87e-06	0.00027	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	9.87e-06	0.00027	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.81e-06	0.000268	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.62e-06	0.000263	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.57e-06	0.000261	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	9.48e-06	0.000259	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	9.33e-06	0.000255	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.32e-06	0.000255	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.18e-06	0.000251	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.18e-06	0.000251	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.18e-06	0.000251	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	9.01e-06	0.000246	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	9.01e-06	0.000246	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	9.01e-06	0.000246	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	9.01e-06	0.000246	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	8.85e-06	0.000242	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.8e-06	0.00024	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.8e-06	0.00024	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	8.67e-06	0.000237	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	8.67e-06	0.000237	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.67e-06	0.000237	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	8.64e-06	0.000236	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	8.5e-06	0.000232	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	8.47e-06	0.000231	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	8.47e-06	0.000231	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	8.45e-06	0.000231	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	8.45e-06	0.000231	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	8.45e-06	0.000231	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	8.4e-06	0.000229	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.39e-06	0.000229	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.32e-06	0.000227	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	8.25e-06	0.000225	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.22e-06	0.000225	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.18e-06	0.000223	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.18e-06	0.000223	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.18e-06	0.000223	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	8.15e-06	0.000223	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.13e-06	0.000222	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	8.03e-06	0.000219	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.69e-06	0.00021	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	7.58e-06	0.000207	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	7.58e-06	0.000207	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	7.58e-06	0.000207	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	7.5e-06	0.000205	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	7.44e-06	0.000203	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	7.37e-06	0.000201	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	7.35e-06	0.000201	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	7.35e-06	0.000201	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	7.22e-06	0.000197	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	7.2e-06	0.000197	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.2e-06	0.000197	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.16e-06	0.000196	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	7.16e-06	0.000195	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	7.16e-06	0.000195	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	7.16e-06	0.000195	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	7.11e-06	0.000194	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	6.99e-06	0.000191	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.95e-06	0.00019	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.95e-06	0.00019	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.95e-06	0.00019	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.95e-06	0.00019	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	6.93e-06	0.000189	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	6.91e-06	0.000189	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	6.85e-06	0.000187	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	6.85e-06	0.000187	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	6.68e-06	0.000183	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.67e-06	0.000182	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	6.57e-06	0.000179	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	6.57e-06	0.000179	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.44e-06	0.000176	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	6.42e-06	0.000175	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	6.42e-06	0.000175	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	6.42e-06	0.000175	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	6.3e-06	0.000172	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	6.25e-06	0.000171	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.2e-06	0.000169	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.16e-06	0.000168	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	6.11e-06	0.000167	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.87e-06	0.00016	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	5.81e-06	0.000159	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.79e-06	0.000158	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.67e-06	0.000155	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.67e-06	0.000155	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.66e-06	0.000155	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	5.66e-06	0.000155	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.66e-06	0.000155	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	5.64e-06	0.000154	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.63e-06	0.000154	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	5.57e-06	0.000152	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	5.57e-06	0.000152	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	5.56e-06	0.000152	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.56e-06	0.000152	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.53e-06	0.000151	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.53e-06	0.000151	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.53e-06	0.000151	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.49e-06	0.00015	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	5.4e-06	0.000147	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.39e-06	0.000147	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.33e-06	0.000146	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	5.25e-06	0.000143	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	5.16e-06	0.000141	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	5.05e-06	0.000138	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	5.03e-06	0.000137	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.96e-06	0.000135	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.96e-06	0.000135	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.96e-06	0.000135	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.9e-06	0.000134	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.86e-06	0.000133	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.84e-06	0.000132	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.82e-06	0.000132	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	4.8e-06	0.000131	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.8e-06	0.000131	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.78e-06	0.00013	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.72e-06	0.000129	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	4.71e-06	0.000129	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.64e-06	0.000127	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	4.58e-06	0.000125	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	4.56e-06	0.000124	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.53e-06	0.000124	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.48e-06	0.000122	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.48e-06	0.000122	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.45e-06	0.000122	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	4.41e-06	0.00012	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.37e-06	0.000119	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.34e-06	0.000118	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.32e-06	0.000118	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.3e-06	0.000117	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.3e-06	0.000117	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.28e-06	0.000117	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.27e-06	0.000117	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.26e-06	0.000116	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.15e-06	0.000113	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.1e-06	0.000112	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.93e-06	0.000107	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.86e-06	0.000105	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.77e-06	0.000103	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.74e-06	0.000102	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.7e-06	0.000101	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.7e-06	0.000101	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.69e-06	0.000101	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.69e-06	0.000101	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.67e-06	0.0001	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.66e-06	0.0001	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.64e-06	9.93e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.62e-06	9.88e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.53e-06	9.64e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.43e-06	9.38e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.39e-06	9.24e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.37e-06	9.21e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.3e-06	9.01e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.29e-06	8.98e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.24e-06	8.84e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.24e-06	8.84e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.2e-06	8.75e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.19e-06	8.71e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.16e-06	8.64e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.13e-06	8.54e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.04e-06	8.29e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.98e-06	8.13e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.96e-06	8.09e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.88e-06	7.88e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.87e-06	7.83e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.84e-06	7.74e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.83e-06	7.72e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.79e-06	7.63e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.74e-06	7.49e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.74e-06	7.49e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.51e-06	6.85e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.46e-06	6.72e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.41e-06	6.59e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.21e-06	6.04e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.12e-06	5.78e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.12e-06	5.78e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.94e-06	5.29e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.49e-06	4.06e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.26e-06	3.44e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.73e-07	2.66e-05	CbGpPWpGaD
